-+ 0.00%
-+ 0.00%
-+ 0.00%

Contineum shares fell 9.9% due to the failure of mid-term clinical trials of an antidepressant developed in collaboration with Johnson & Johnson.

Zhitongcaijing·09/15/2026 17:25:03
Listen to the news
Contineum shares fell 9.9% due to the failure of mid-term clinical trials of an antidepressant developed in collaboration with Johnson & Johnson.